Martyn Thomas

Summary

Publications

  1. doi request reprint One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve
    Martyn Thomas
    Director of Cardiovascular Services, Cardiology Department, St Thomas Hospital, Westminster Bridge Rd, London, UK
    Circulation 124:425-33. 2011
  2. pmc Brachytherapy: here today, gone tomorrow?
    M R Thomas
    Department of Cardiology, King s College Hospital, London SE5 9RS, UK
    Heart 91:iii32-4. 2005
  3. ncbi request reprint The global experience with percutaneous aortic valve replacement
    Martyn Thomas
    Cardiovascular Services, Guys and St Thomas Hospital, London, UK
    JACC Cardiovasc Interv 3:1103-9. 2010
  4. doi request reprint Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve
    Martyn Thomas
    St Thomas Hospital, London, UK
    Circulation 122:62-9. 2010
  5. pmc Interventional cardiology and the medical devices industry: is there a conflict of interest?
    Martyn Thomas
    King s College Hospital, Denmark Hill, London SE5 9RS, UK
    Heart 93:1351-2. 2007
  6. doi request reprint Transapical aortic valve implantation: mid-term outcome from the SOURCE registry
    Olaf Wendler
    Department of Cardiothoracic Surgery, King s Health Partners, London, UK
    Eur J Cardiothorac Surg 43:505-11; discussion 511-2. 2013
  7. doi request reprint Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results
    Vinayak Bapat
    Department of Cardiothoracic Surgery and Cardiology, Guys and St Thomas Hospital, London, United Kingdom
    J Thorac Cardiovasc Surg 144:1372-9; discussion 1379-80. 2012
  8. doi request reprint The SOURCE Registry: what is the learning curve in trans-apical aortic valve implantation?
    Olaf Wendler
    Department of Cardiothoracic Surgery, King s Health Partners, London, UK
    Eur J Cardiothorac Surg 39:853-9; discussion 859-60. 2011
  9. doi request reprint A guide to fluoroscopic identification and design of bioprosthetic valves: a reference for valve-in-valve procedure
    Vinayak Bapat
    Department of Cardiothoracic Surgery and Cardiology, Guys and St Thomas Hospital, London, United Kingdom
    Catheter Cardiovasc Interv 81:853-61. 2013
  10. ncbi request reprint Fluoroscopic guide to an ideal implant position for Sapien XT and CoreValve during a valve-in-valve procedure
    Vinnie N Bapat
    Department of Cardiothoracic Surgery, St Thomas Hospital, London, United Kingdom Electronic address
    JACC Cardiovasc Interv 6:1186-94. 2013

Collaborators

Detail Information

Publications33

  1. doi request reprint One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve
    Martyn Thomas
    Director of Cardiovascular Services, Cardiology Department, St Thomas Hospital, Westminster Bridge Rd, London, UK
    Circulation 124:425-33. 2011
    ..Transcatheter aortic valve implantation was developed to provide a therapeutic option for patients considered to be ineligible for, and to mitigate mortality and morbidity associated with, high-risk surgical aortic valve replacement...
  2. pmc Brachytherapy: here today, gone tomorrow?
    M R Thomas
    Department of Cardiology, King s College Hospital, London SE5 9RS, UK
    Heart 91:iii32-4. 2005
  3. ncbi request reprint The global experience with percutaneous aortic valve replacement
    Martyn Thomas
    Cardiovascular Services, Guys and St Thomas Hospital, London, UK
    JACC Cardiovasc Interv 3:1103-9. 2010
    ..This review describes the current data with this technology and also the potential for the future role of the technology, including potential ways to yet further improve the short- and longer-term results...
  4. doi request reprint Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve
    Martyn Thomas
    St Thomas Hospital, London, UK
    Circulation 122:62-9. 2010
    ..The Edwards SAPIEN valve was approved for transcatheter aortic valve implantation transfemoral delivery in the European Union in November 2007 and for transapical delivery in January 2008...
  5. pmc Interventional cardiology and the medical devices industry: is there a conflict of interest?
    Martyn Thomas
    King s College Hospital, Denmark Hill, London SE5 9RS, UK
    Heart 93:1351-2. 2007
  6. doi request reprint Transapical aortic valve implantation: mid-term outcome from the SOURCE registry
    Olaf Wendler
    Department of Cardiothoracic Surgery, King s Health Partners, London, UK
    Eur J Cardiothorac Surg 43:505-11; discussion 511-2. 2013
    ..Transapical (TA) aortic valve implantation using the Edwards SAPIEN bioprosthesis was commercially introduced in Europe in January 2008. Limited data on the mid-term results are available...
  7. doi request reprint Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results
    Vinayak Bapat
    Department of Cardiothoracic Surgery and Cardiology, Guys and St Thomas Hospital, London, United Kingdom
    J Thorac Cardiovasc Surg 144:1372-9; discussion 1379-80. 2012
    ..We report our experience with transcatheter aortic valve implantation in the treatment of degenerated biologic aortic valve prostheses and discuss factors that can influence the outcome...
  8. doi request reprint The SOURCE Registry: what is the learning curve in trans-apical aortic valve implantation?
    Olaf Wendler
    Department of Cardiothoracic Surgery, King s Health Partners, London, UK
    Eur J Cardiothorac Surg 39:853-9; discussion 859-60. 2011
    ..Using the SOURCE Registry, we analyze the learning curve for TA-AVI over the first 2 years after commercialization...
  9. doi request reprint A guide to fluoroscopic identification and design of bioprosthetic valves: a reference for valve-in-valve procedure
    Vinayak Bapat
    Department of Cardiothoracic Surgery and Cardiology, Guys and St Thomas Hospital, London, United Kingdom
    Catheter Cardiovasc Interv 81:853-61. 2013
    ..We have also collated relevant information on the aspects of the design of a bioprosthetic valve, which are relevant to the valve-in-valve procedure...
  10. ncbi request reprint Fluoroscopic guide to an ideal implant position for Sapien XT and CoreValve during a valve-in-valve procedure
    Vinnie N Bapat
    Department of Cardiothoracic Surgery, St Thomas Hospital, London, United Kingdom Electronic address
    JACC Cardiovasc Interv 6:1186-94. 2013
    ..This study sought to provide a guide to the fluoroscopic appearances of various valve-in-valve (VIV) combinations by deploying a transcatheter heart valve (THV) within a degenerated surgical heart valve (SHV) in an ideal position...
  11. doi request reprint Trans-apical aortic valve implantation: univariate and multivariate analyses of the early results from the SOURCE registry
    Olaf Wendler
    Department of Cardiothoracic Surgery, King s Health Partners, London, UK
    Eur J Cardiothorac Surg 38:119-27. 2010
    ..Currently, the results of trans-apical trans-catheter procedures performed outside controlled trials are unknown...
  12. doi request reprint Distribution of calcium in the ascending aorta in patients undergoing transcatheter aortic valve implantation and its relevance to the transaortic approach
    Vinayak N Bapat
    Department of Cardiothoracic Surgery, St Thomas Hospital, London, United Kingdom
    JACC Cardiovasc Interv 5:470-6. 2012
    ..This study sought to identify how many patients suitable for transcatheter aortic valve implantation (TAVI) would have a contraindication for the transaortic (TAo) approach due to ascending aortic calcification...
  13. ncbi request reprint Standalone balloon aortic valvuloplasty: indications and outcomes from the UK in the transcatheter valve era
    Muhammed Z Khawaja
    Cardiovascular Division, BHF Center of Excellence, King s College London, St Thomas Hospital, London, United Kingdom
    Catheter Cardiovasc Interv 81:366-73. 2013
    ..We sought to characterize UK-wide balloon aortic valvuloplasty (BAV) experience in the TAVI era...
  14. doi request reprint Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2
    Bernard Chevalier
    Institut Cardiovasculaire Paris Sud, Massy Quincy, France
    Circ Cardiovasc Interv 2:188-95. 2009
    ..The newly developed Nobori coronary stent coated with a bioresorbable polymer, polylactic acid, and the antiproliferative agent Biolimus A9 has the potential to reduce restenosis by suppressing neointima formation...
  15. ncbi request reprint Angiographic and clinical restenosis following the use of long coronary Wallstents
    I L Williams
    Department of Cardiology, King s College Hospital, London, England
    Catheter Cardiovasc Interv 48:287-93; discussion 294-5. 1999
    ..The Wallstent can be deployed in complex lesions with a high primary success rate and an acceptably low restenosis rate. The optimal management of in-stent restenosis remains to be defined...
  16. ncbi request reprint Transaortic transcatheter aortic valve implantation for failed surgical aortic valve replacement due to 'porcelain aorta'
    Rizwan Q Attia
    Department of Cardiothoracic Surgery, St Thomas Hospital, London, UK
    J Heart Valve Dis 22:85-8. 2013
    ..The patient recovered well and was discharged home without any complications...
  17. doi request reprint Transaortic Transcatheter Aortic valve implantation using Edwards Sapien valve: a novel approach
    Vinayak Bapat
    Department of Cardiothoracic Surgery, Guy s and St Thomas Hospital, London, United Kingdom
    Catheter Cardiovasc Interv 79:733-40. 2012
    ..To evaluate feasibility and outcome of Transoartic Transcatheter Sapien valve implantation...
  18. ncbi request reprint First successful trans-catheter aortic valve implantation through ascending aorta using Edwards SAPIEN THV system
    Vinayak Bapat
    Department of Cardiothoracic Surgery and Cardiology, Guy s and St Thomas Hospital, London, UK
    Eur J Cardiothorac Surg 38:811-3. 2010
    ..We describe a case where conventional trans-catheter approaches, that is, transfemoral or trans-apical using the Edwards THV system, were not possible but successful implantation was achieved through the trans-aortic route...
  19. ncbi request reprint Intravascular ultrasound-guided stenting in long lesions: an insight into possible mechanisms of restenosis and comparison of angiographic and intravascular ultrasound data from the MUSIC and RENEWAL trials
    T Nageh
    King s College Hospital, Denmark Hill, London, England SE5 9RS
    J Interv Cardiol 14:397-405. 2001
    ..Therefore, suboptimal stent deployment due to constraint by lesion resistance may be an important mechanism underlying the high restenosis rates in long stents...
  20. doi request reprint Virtual fractional flow reserve by coronary computed tomography - hope or hype?
    Ronak Rajani
    Department of Cardiology, St Thomas Hospital, London, United Kingdom
    EuroIntervention 9:277-84. 2013
    ....
  21. ncbi request reprint Warfarin-induced skin necrosis and heparin-induced thrombocytopenia following mitral valve replacement for marantic endocarditis
    Craig A White
    King s College Hospital, London, UK
    J Heart Valve Dis 15:716-8. 2006
    ..Thrombophilia in the face of endocarditis should be treated with a suspicion of underlying cancer...
  22. doi request reprint Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial
    Divaka Perera
    Cardiovascular Division, King s College London, London SE1 7EH, UK
    JAMA 304:867-74. 2010
    ..To date, this assertion has not been tested in a randomized trial...
  23. ncbi request reprint Non-flow limiting dissection leading to late coronary restenosis following intracoronary brachytherapy
    D R McClean
    King's College Hospital, London, UK
    Catheter Cardiovasc Interv 54:355-7. 2001
    ..No dissection was seen immediately following the initial procedure. Subsequent late healing of the dissection led to marked restenosis and the development of angina 14 months after the index procedure...
  24. ncbi request reprint A randomised trial of endoluminal reconstruction comparing the NIR stent and the Wallstent in angioplasty of long segment coronary disease: results of the RENEWAL Study
    T Nageh
    Department of Cardiology, King s College Hospital, London, UK
    Am Heart J 141:971-6. 2001
    ..By comparing the outcome of treating long lesions with two different stent types, we aimed to assess the influence of stent design rather than the nature of long lesions per se on the relatively high restenosis rates in this subgroup...
  25. ncbi request reprint Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature
    Krys Milburn
    Cardiovascular Department, Guys and St Thomas Hospital, 6th Floor, East Wing, Westminster Bridge Road, London, SE1 7EH, UK
    Clin Res Cardiol 103:417-29. 2014
    ..We review the current literature to assess whether this technique may be the new standard for degenerated bioposthesis. ..
  26. ncbi request reprint High-speed rotational atherectomy in the treatment of bifurcation-type coronary lesions
    T Nageh
    King's College Hospital, London, UK
    Cardiology 95:198-205. 2001
    ..01). Outcome at follow-up favoured the HSRA/stent group, although the difference did not reach statistical significance. CONCLUSION: HSRA with provisional stenting provided a safe and effective means of treating bifurcation lesions...
  27. pmc Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease
    T Nageh
    Department of Cardiology, King s College Hospital, Denmark Hill, London SE5 9RS, UK
    Heart 91:1181-5. 2005
    ..To assess the role of cardiac troponin I (cTnI) in predicting outcome after percutaneous coronary intervention (PCI)...
  28. pmc Coronary artery perforation during percutaneous intervention: incidence and outcome
    M G Gunning
    Department of Cardiology, Kings College Hospital, London, UK
    Heart 88:495-8. 2002
    ..To examine the clinical outcome of percutaneous coronary intervention where the procedure was complicated by vessel perforation...
  29. ncbi request reprint Recent advances in percutaneous coronary intervention
    Arun Patil
    Hosp Med 64:132-3. 2003
  30. ncbi request reprint Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST)
    Juergen vom Dahl
    Medizinische Klinik I, Universitatsklinikum, Rheinisch Westfaelische Technische Hochschule Aachen, Germany
    Circulation 105:583-8. 2002
    ....
  31. ncbi request reprint Life-threatening coronary artery spasm following sirolimus-eluting stent deployment
    Stephen Wheatcroft
    J Am Coll Cardiol 47:1911-2; author reply 1912-3. 2006
  32. ncbi request reprint Revascularization for ischemic LV dysfunction: stents or surgery?
    Martyn Thomas
    Catheter Cardiovasc Interv 70:34. 2007
  33. ncbi request reprint Classification of coronary artery bifurcation lesions and treatments: time for a consensus!
    Yves Louvard
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 71:175-83. 2008
    ..They are often small scale and display methodological flaws and other shortcomings such as inaccurate designation of lesions, heterogeneity, and inadequate description of techniques implemented...